{
    "clinical_study": {
        "@rank": "161338", 
        "arm_group": {
            "arm_group_label": "Genexol-PM/Gemcitabine", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the efficacy and safety Genexol-PM(CrEL-free polymeric micelle formulated\n      paclitaxel)and gemcitabine in untreated metastatic NSCLC patients"
        }, 
        "brief_title": "A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer", 
        "condition": "Non-small Cell Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age over 18\n\n          -  histologically or cytologically confirmted non-small cell lung cancer\n\n          -  stage IIIb with pleural effusion or stage IV\n\n          -  ECOG PS 0-2\n\n          -  at least one measurable lesion\n\n          -  expected life span more than 3 months\n\n          -  normal bone marrow, liver, renal function\n\n          -  no prior chemotherapy or radiotherapy except for whole brain radiotherapy for\n             symptomatic brain metastases\n\n          -  more than 6 months from the last adjuvant chemotherapy\n\n        Exclusion Criteria:\n\n          -  active infection\n\n          -  severe comorbitidies\n\n          -  pregnant or lactating women\n\n          -  other invasive malignancies\n\n          -  poorly controlled symptomatic brain metastases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01770795", 
            "org_study_id": "2011-GIRBA-2351"
        }, 
        "intervention": {
            "arm_group_label": "Genexol-PM/Gemcitabine", 
            "intervention_name": "Genexol-PM/Gemcitabine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Gemcitabine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "non-small cell lung cancer", 
            "gemcitabine", 
            "genexol-PM", 
            "paclitaxel"
        ], 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Gachon University Gil Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Overall response rate", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01770795"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gachon University Gil Medical Center", 
            "investigator_full_name": "Eun Kyung Cho", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "progression free survival", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "overall survival", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "toxicities", 
                "safety_issue": "Yes", 
                "time_frame": "one year"
            }
        ], 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}